Literature DB >> 17100815

Abnormal Doppler velocimetry is related to adverse perinatal outcome for borderline amniotic fluid index during third trimester.

Ja-Young Kwon1, Han-Sung Kwon, Young-Han Kim, Yong-Won Park.   

Abstract

AIM: To evaluate the relationship between abnormal Doppler velocimetry and adverse perinatal outcomes in pregnancies with borderline amniotic fluid index (AFI).
METHODS: Medical records of 3740 pregnancies with known AFI and Doppler velocimetry measurements within 2 weeks of delivery, and delivered between January 1996 and December 2003, were retrospectively analyzed. Borderline AFI was defined as 5 cm < AFI < or = 8 cm. For the umbilical artery, Doppler velocimetry was considered abnormal when the S/D ratio was greater than 3.0 or when end-diastolic flow was absent; whereas, for the uterine artery, the S/D ratio was greater than 2.6 or presence of end-systolic notch was defined as abnormal. Adverse perinatal outcomes (small for gestational age, cesarean section for fetal distress, 5 min Apgar score of less than 7, respiratory distress syndrome, NICU admission, and perinatal death) according to Doppler velocimetry in borderline AFI were evaluated.
RESULTS: Compared to the normal AFI group (n = 3523), the borderline AFI group (n = 217) had significantly higher incidence of adverse perinatal outcome (28.8% vs 54.8%). There was 3-fold increase in the incidence of adverse perinatal outcome among women with the borderline AFI in comparison to normal AFI (OR, 3.00; CI, 2.27-4.00). When abnormal Doppler velocimetry was associated with borderline AFI, a 5-fold increase in the incidence of adverse perinatal outcome was noted (OR, 5.26; CI, 3.00-9.21).
CONCLUSION: In the borderline AFI group, the presence of abnormal Doppler velocimetry measurement was related to increased risk of adverse perinatal outcome. Thus, borderline AFI of 5-8 cm, especially when associated with abnormal Doppler velocimetry, mandates closer antenatal surveillance.

Entities:  

Mesh:

Year:  2006        PMID: 17100815     DOI: 10.1111/j.1447-0756.2006.00459.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  7 in total

1.  Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.

Authors:  Gordon Cs Smith; Alexandros A Moraitis; David Wastlund; Jim G Thornton; Aris Papageorghiou; Julia Sanders; Alexander Ep Heazell; Stephen C Robson; Ulla Sovio; Peter Brocklehurst; Edward Cf Wilson
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

2.  Perinatal outcomes of pregnancies with borderline versus normal amniotic fluid index.

Authors:  Maryam Asgharnia; Roya Faraji; Fatemeh Salamat; Babak Ashrafkhani; Seyedeh Fatemeh Dalil Heirati; Samira Naimian
Journal:  Iran J Reprod Med       Date:  2013-09

3.  Adverse perinatal outcomes in borderline amniotic fluid index.

Authors:  Ashraf Jamal; Maryam Kazemi; Vajiheh Marsoosi; Laleh Eslamian
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-11

4.  Utility of Doppler parameters at 36-42 weeks' gestation in the prediction of adverse perinatal outcomes in appropriate-for-gestational-age fetuses.

Authors:  Michał Migda; Katarzyna Gieryn; Bartosz Migda; Marian Stanisław Migda; Marek Maleńczyk
Journal:  J Ultrason       Date:  2018-03-30

5.  Comparison of Perinatal and Maternal Outcomes in Borderline Versus Normal Amniotic Fluid Index in a Tertiary Care Center in Odisha: An Observational Prospective Study.

Authors:  Anuradha Vyas; G Prasanna; Sudarshan Dash; Sudhansu Rath
Journal:  Cureus       Date:  2021-11-24

6.  Umbilical Artery Systolic/Diastolic Ratio and Amniotic Fluid Index in Prediction of Adverse Perinatal Outcome in Term Pregnancies.

Authors:  Medhavi Sharma; Gaurav Sharma; Anjana Verma
Journal:  Int J Appl Basic Med Res       Date:  2022-05-10

7.  Evaluation of Maternal and Perinatal Outcomes of Induction in Borderline Oligohydramnios at Term.

Authors:  Setu Rathod; Sunil Kumar Samal
Journal:  J Clin Diagn Res       Date:  2017-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.